A later study uncovered that increased KLF6-SV1 and reduced expression of KLF6 are frequent representations in GBM and the overexpression of KLF6-SV1 antagonize wild-type KLF6-mediated growth inhibition (Camacho-Vanegas et al., 2007). The gene discussed is KLF6; the disease is glioblastoma.